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Absence seizures in children and teenagers are generally considered relatively benign because of their non-convulsive nature and
the large incidence of remittance in early adulthood. Recent studies, however, show that 30% of children with absence seizures are
pharmaco-resistant and 60% are affected by severe neuropsychiatric comorbid conditions, including impairments in attention, cog-
nition, memory and mood. In particular, attention deficits can be detected before the epilepsy diagnosis, may persist even when
seizures are pharmacologically controlled and are aggravated by valproic acid monotherapy. New functional MRI-magnetoence-
phalography and functional MRI-EEG studies provide conclusive evidence that changes in blood oxygenation level-dependent sig-
nal amplitude and frequency in children with absence seizures can be detected in specific cortical networks at least 1 min before the
start of a seizure, spike-wave discharges are not generalized at seizure onset and abnormal cortical network states remain during
interictal periods. From a neurobiological perspective, recent electrical recordings and imaging of large neuronal ensembles with
single-cell resolution in non-anaesthetized models show that, in contrast to the predominant opinion, cortical mechanisms, rather
than an exclusively thalamic rhythmogenesis, are key in driving seizure ictogenesis and determining spike-wave frequency. Though
synchronous ictal firing characterizes cortical and thalamic activity at the population level, individual cortico-thalamic and thala-
mocortical neurons are sparsely recruited to successive seizures and consecutive paroxysmal cycles within a seizure. New evidence
strengthens previous findings on the essential role for basal ganglia networks in absence seizures, in particular the ictal increase in
firing of substantia nigra GABAergic neurons. Thus, a key feature of thalamic ictogenesis is the powerful increase in the inhibition
of thalamocortical neurons that originates at least from two sources, substantia nigra and thalamic reticular nucleus. This undoubt-
edly provides a major contribution to the ictal decrease in total firing and the ictal increase of T-type calcium channel-mediated
burst firing of thalamocortical neurons, though the latter is not essential for seizure expression. Moreover, in some children and
animal models with absence seizures, the ictal increase in thalamic inhibition is enhanced by the loss-of-function of the astrocytic
GABA transporter GAT-1 that does not necessarily derive from a mutation in its gene. Together, these novel clinical and experi-
mental findings bring about paradigm-shifting views of our understanding of absence seizures and demand careful choice of initial
monotherapy and continuous neuropsychiatric evaluation of affected children. These issues are discussed here to focus future clin-
ical and experimental research and help to identify novel therapeutic targets for treating both absence seizures and their
comorbidities.
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Introduction
Absence seizures are sudden, relatively brief lapses of con-
sciousness associated with lack of voluntary movements and
distinctive electrographic spike-wave discharges (SWD) at
2.5–4 Hz (Fig. 1A) (Panayiotopoulos, 1999, 2008; Crunelli
and Leresche, 2002b; Blumenfeld, 2005b; Matricardi et al.,
2014). These generalized non-convulsive seizures mostly
have a polygenic background and can be present together
with other seizure types in various age-dependent and age-
independent epilepsies with different rates of remittance and
expected outcomes (Crunelli and Leresche, 2002b; Camfield
and Camfield, 2005; Gardiner, 2005; Fisher et al., 2017;
Scheffer et al., 2017). The personal, familial and societal
burden of absence seizures is considerable, being influenced
by the immediate symptoms of the seizures and the common
psychiatric comorbidities, including attentional, cognitive,
memory and mood impairments (Masur et al., 2013; Cnaan
et al., 2017). Moreover, the high incidence of pharmaco-
resistance (Glauser et al., 2013) and the persistence of
comorbidities even after full control of the seizures (Masur
et al., 2013; Holmes and Noebels, 2016) highlight the need
of an improved and holistic mechanistic understanding to fa-
cilitate the development of novel medications and other
therapeutic approaches that effectively address the entirety
of the disease, i.e. seizures and comorbid conditions.
Achieving such mechanistic knowledge has undoubtedly
been challenging, given the often unrecognized large spec-
trum of absence seizure semiology and EEG features, the
lack of suitable biomarkers, the heterogeneity of (and lack
of drug-free) cohorts used in many studies, the ethical
restrictions of invasive clinical studies and the less than opti-
mal experimental conditions used in some studies in animal
models. Notwithstanding these difficulties and limitations,
advancements with significant clinical implications are being
made.
Here, we discuss novel insights on absence seizure initi-
ation, ictogenesis, comorbidity and therapy that have origi-
nated both from non-invasive human studies and invasive
investigations in animal models. Points of controversy and
crucial gaps in knowledge will be highlighted raising ques-
tions that should contribute to improve current clinical prac-
tice and to focus future clinical and experimental research.
The emphasis will mainly be on absence seizure of childhood
absence epilepsy (CAE) (where these seizures are the only
clinical symptom) and on animal models with an absence
seizure-only phenotype, as in these children and model sys-
tems the epileptogenesis and ictogenesis of absence seizures
are not compromised or modulated by the concomitant pres-
ence of other types of seizures. Nevertheless, many of the
findings, key issues and conclusions raised and discussed in
this review do apply to absence seizures that are present in
other epilepsies (Guo et al., 2016; Tangwiriyasakul et al.,
2018).
Spectrum of clinical symptoms and
electrographic features of absence
seizures
Contrary to the classical textbook illustration of regular
2.5–4 Hz SWD (Fig. 1A), the electrographic presentation
of absence seizures can be highly variable even in the
same individual and may include SWD with different
amplitudes and durations, absence of spikes, presence
of double spikes and a progressive decrease in frequency
towards the end of the paroxysm (Fig. 1B)
(Panayiotopoulos, 1999). Moreover, the secondary clinic-
al symptoms of absence seizure (e.g. automatisms, atonic
and tonic muscular components, mild clonic eye or mouth
jerks etc.) may be highly variable among children and dur-
ing different absence seizure in the same child. The pri-
mary loss of consciousness itself is also variable and a
recent study combining functional MRI, EEG and atten-
tional tests has directly demonstrated the broad spectrum
of cognitive impairments that is associated with different
absence seizures, with some seizures showing a fully
spared attention (Fig. 1C) (Guo et al., 2016).
A similarly large spectrum of absence seizure electro-
graphic and behavioural features is also present in various
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genetic and pharmacological animal models and even in the
same mouse or rat during successive absence seizures.
However, animal models do show differences with human
absence seizures, including a higher SWD frequency at 5–11
Hz and lack of absence seizure remittance with age [for
comprehensive summaries of similarities and differences of
absence seizures between humans and animal models, see
Pitka¨nen et al. (2017)]. In this context, it is important to
mention that two recent studies have questioned the validity
of current rodent models of absence seizure because (i) these
model rats can modify the duration of their SWD (suggest-
ing that they are not adverse events) (Taylor et al., 2017);
and (ii) absence seizure-like events are present in wild-caught
rats (implying that they are unlikely to represent a patho-
logical trait) (Taylor et al., 2019). Whereas the results of
both studies are welcome as they directly confirm and en-
large anecdotal evidence and previous scientific findings
made in inbred and outbred rat strains since the 1980s, their
interpretations and conclusions do not consider the variabil-
ity in clinical symptoms and electrophysiological features
that are present in human absence seizures.
The issue raised by the first study (Taylor et al., 2017) has
been extensively debated previously (Depaulis et al., 2017)
and will thus not be addressed further here except for
emphasizing that the broad spectrum of clinical symptoms
in affected children (and adults) includes absence seizures
that are associated with both impaired and unimpaired at-
tention (Fig. 1C) (Guo et al., 2016). Regarding the issue
raised by the second study (Taylor et al., 2019), the majority
(65%) of SWD recorded by these authors in wild-caught
rats are 51 s long (and none42 s) and would thus be con-
sidered to be subclinical seizures, i.e. absence seizures for
which the electrographic but not the cognitive and behav-
ioural components may be evident and measurable. Indeed,
such short subclinical SWD rarely have an overt clinical cor-
relate and absence seizures with spared attention tend to
have a very short duration (3 s) (Guo et al., 2016).
Nevertheless, the study of Taylor et al. (2019) strengthens
the view that the potential presence of ethosuximide-sensitive
SWD in various ‘normal’ (i.e. non-epileptic) inbred and out-
bred mouse and rat colonies should always be carefully con-
sidered when selecting an appropriate control group for
comparison with mouse and rat absence seizure model
strains. In other words, animals used as the control group
should whenever possible be screened for the presence of ab-
sence seizures before inclusion in comparative experiments.
Absence seizure initiation
The pioneering non-linear analysis of multi-site local field
potentials in cortico-thalamic networks carried out by
Meeren et al. (2002) in a genetic model of absence seizures,
the Wistar Albino Glaxo from Rijswijk (WAG/Rij) rats
(Depaulis and van Luijtelaar, 2006) showed for the first
time the key role of a localized cortical region (the peri-oral
region of primary somatosensory cortex) in the initiation of
absence seizures. Later work in another genetic model, the
Genetic Absence Epilepsy Rats from Strasbourg, GAERS
(Depaulis and van Luijtelaar, 2006), characterized the barrel
field region of primary somatosensory cortex (Studer et al.,
2018) and layer 5/6 excitatory pyramidal neurons (Polack
et al., 2007) as the originators of the initial paroxysmal ac-
tivity. Indeed, absence seizures in GAERS rats are abolished
by blocking the firing of these neurons (Polack et al., 2009),
Figure 1 Spectrum of SWD features and attention levels
in children with absence seizures. (A) Characteristic EEG
presentation of SWD in CAE. [B(i)] A long SWD with variable
cycle waveform (left trace) was associated with lack of conscious-
ness (indicated by the interruption of counting in the period marked
by the two arrows) while a short SWD (right trace) in the same
CAE child was not. [B(ii)] SWD with double spikes (enlarged on
the right). [B(iii)] A long, hyperventilation-induced SWD from an-
other child with CAE. (C) Different absence seizures, characterized
by small and large changes in BOLD signal amplitude and 2.5–4 Hz
EEG power, are associated with spared and impaired attention, re-
spectively. DMN = default-mode network; TPN = task-positive
network; SMT = sensorimotor-thalamic network. A is modified
from Cerminara et al. (2012), and C from Guo et al. (2016).
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and are more susceptible to ethosuximide applied in the pri-
mary somatosensory cortex than the motor cortex or ventro-
basal thalamus (Richards et al., 2003; Manning et al.,
2004). Notably, a recent study (Lee et al., 2019) has shown
that whereas spontaneous SWD in PLC-b4 knockout mice
originate in the somatosensory cortex, the majority of SWD
in the pharmacological c-hydroxybutyric acid (GHB) model
(Snead, 1992; Venzi et al., 2015) appear first in the prefront-
al cortex, indicating different sites of SWD initiation in dif-
ferent mouse and rat, genetic and pharmacological models
as in children with absence seizures (see below).
Studies in humans
Blood oxygenation level-dependent (BOLD) functional MRI
studies have been critical in identifying key regions involved
in human absence seizures (Aghakhani et al., 2004; Gotman
et al., 2005; Hamandi et al., 2006; Moeller et al., 2008). In
particular, the lack of generalization at the start of an ab-
sence seizure has now been confirmed in many multi-modal
investigations of young, adolescent and adult populations
with absence seizures, including high-density EEG, MEG
and functional MRI studies in which localized changes in
precuneus, posterior cingulate cortex, lateral parietal cortex
and/or frontal cortex are observed before other brain areas
become involved in the paroxysm (Holmes et al., 2004;
Westmijse et al., 2009; Carney et al., 2010; Bai et al., 2011;
Gupta et al., 2011; Benuzzi et al., 2012; Tenney et al., 2013;
Wu et al., 2017). Indeed, the first study on a pure CAE co-
hort reported increases in BOLD signal amplitude occurring
from 14 s before the clinical and electrographic signatures of
a seizure could be observed (Bai et al., 2010) (Fig. 2A).
Notably, the cortical area(s) where these pre-ictal increases
in BOLD amplitude occur may differ from child to child but
are mostly consistent between seizures for a given child (Bai
et al., 2010, 2011; Moeller et al., 2010). Importantly, from
absence seizure onset the same cortical areas show a
decreased BOLD signal amplitude that may persist for up to
10 s after the end of the seizure (Bai et al., 2010; Moeller
et al., 2010; Benuzzi et al., 2012).
Whereas the above functional MRI studies investigated
changes in BOLD amplitude, a recent study has analysed the
phase-synchrony of BOLD signals in people with generalized
SWD, including a small CAE cohort (Tangwiriyasakul et al.,
2018). These authors found that there is persistently
increased synchrony in a sensorimotor cortical network dur-
ing non-ictal periods. At least 1 min prior to absence seizure,
synchrony in an occipital cortical network begins to decrease
(Fig. 2B). Then, from around 10 s prior to SWD onset, the
hubs of a SWD-specific cortical network (involving prefront-
al regions, precuneus, medial parietal cortex, and medial
and lateral prefrontal cortex) begin to show a linear increase
in synchrony. Together, this indicates that a persistently ab-
normal sensorimotor network may represent a ‘pre-ictal’
brain state that can smoothly progress to an ictal SWD net-
work (Fig. 2B). Notably, a high level of synchrony is still ap-
parent in the SWD network 20 s after the end of the
electrographic paroxysmal activity, after which the brain
reverts to the pre-SWD state (Tangwiriyasakul et al., 2018).
In summary, this work demonstrates for the first time the
presence of a persistently, i.e. ictally and interictally, altered
cortical sensorimotor network in people with absence seiz-
ure, a finding of great significance for our understanding of
the pathophysiology of these seizures and their comorbidities
(see ‘Neuropsychiatric comorbidities of absence seizures’
section).
The existence of altered resting state functional connectiv-
ity that may underlie some of the inter-ictal behavioural
impairments is supported by the correlation between
decreased medial frontal cortex activation during a cognitive
task and impaired task performance in CAE (Bai et al.,
2011; Killory et al., 2011; Vega et al., 2011; Luo et al.,
2014). Furthermore, the variable extent of behavioural
impairments during absence seizures has been shown to cor-
relate with the magnitude of ictal BOLD amplitude changes,
providing the first indications of where the behavioural com-
ponent of the seizures might be mediated (Fig. 1B) (Berman
et al., 2010; Guo et al., 2016).
Studies in animal models
Attempts to gain additional mechanistic insights by compar-
ing non-invasive imaging in humans with simultaneous non-
invasive imaging and invasive recordings in animal models
have, however, so far been hampered by the fact that rodent
models of absence seizures do not show the widespread cor-
tical ictal and post-ictal decreases in multi-modal haemo-
dynamic measurements (functional MRI, cerebral blood
flow and volume) (Tenney et al., 2004; David et al., 2008;
Mishra et al., 2011) as observed in humans (Bai et al., 2010;
Moeller et al., 2010; Benuzzi et al., 2012). These conflicting
results are not due to the frequency difference between ro-
dent and human SWD (5–11 Hz and 2.5–4 Hz, respectively)
as anaesthetized ferrets, which exhibit 3 Hz SWD, show cor-
tical functional MRI increases (Youngblood et al., 2015).
This clinical-experimental discrepancy must then be
explained by either a mechanistic limitation of absence seiz-
ure models, differences in higher cortical function between
humans and animals, a peculiarity of human versus lower
mammal neurovascular coupling or an effect of the anaes-
thetics hitherto used in the animal imaging studies. A com-
bination of these factors is also possible: ictal cortical BOLD
amplitude changes in awake GAERS rats (Kratochvil et al.,
2018) are similar to those in individuals with absence seiz-
ures, as are those in Sprague Dawley rats administered the
pro-absence drug GHB (Venzi et al., 2015) after recovery
from ketamine/medetomidine anaesthesia (Tenney et al.,
2003), though WAG/Rij rats still express cortical increases
in the same ketamine/medetomidine recovery conditions
(Tenney et al., 2004). In summary, given these apparent dis-
crepancies between models (GHB versus WAG/Rij) and
drug conditions (GAERS drug-free versus WAG/Rij anaes-
thetized and WAG/Rij post-anaesthesia), a greater under-
standing of the case-specific influences on neurovascular
coupling (Lemieux et al., 2011; Sieu et al., 2015) is required
if any insight into the translational relevance or indeed the
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mechanisms of absence seizure is to be gained from non-
invasive imaging in absence seizure animal models.
Significance of new evidence
A number of important implications derive from the findings
outlined above.
First, the existence of well-delineated cortical networks or
regions where haemodynamic and electrographic changes
are first observed before spreading to other areas has raised
the question of whether absence seizures should still be con-
sidered ‘generalized’ events (van Luijtelaar et al., 2014;
Lu¨ttjohann and Van Luijtelaar, 2015). This early pre-ictal
cortical activity of absence seizure is a phenomenon very dis-
tinct from the structural and functional alterations that char-
acterize the ‘focus’ of focal onset seizures (Fisher et al.,
2017; Scheffer et al., 2017), thus emphasizing that the word
‘focus’ should not be used for absence seizures, as has
occurred recently (van Luijtelaar and Sitnikova, 2006;
Lu¨ttjohann et al., 2011, 2014; Paz and Huguenard, 2015).
Rather, in view of the many and far-located areas contribu-
ting to the pre-ictal changes of absence seizure, these cortical
regions could be accurately referred to as the cortical
Figure 2 BOLD signal changes precede absence seizures and persist interictally. (A) Changes in functional MRI BOLD signal ampli-
tude are present in children with absence seizures 14 s before the clinical and electrographic signatures of a seizure are manifested. (B) In individ-
uals with generalized SWD, including a small CAE cohort, an increase in the phase-synchrony of functional MRI BOLD signals is present in a
‘spike-wave cortical network’ from a few seconds before until 20 s after a seizure (top left) (nodes on the far right column). There is also a
decreased phase-synchrony in an ‘occipital cortical network’ that starts at least 1 min prior to seizure onset (bottom left). Altered phase-syn-
chrony of BOLD signals in the ‘sensorimotor cortical network’ persists interictally but is not present in healthy controls (middle). Modified from
Bai et al. (2010) and Tangwiriyasakul et al. (2018).
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initiation network (CIN). With this distinction in mind, the
current classification of absence seizures as generalized seiz-
ures (Fisher et al., 2017; Scheffer et al., 2017) remains clinic-
ally appropriate and useful.
Second, larger studies of individuals with absence seizures
may disclose different CINs than those so far uncovered (Bai
et al., 2010; Tangwiriyasakul et al., 2018) (see also Carney
et al., 2012; Masterton et al., 2013). In turn, these diverse
networks may be potentially correlated with different geno-
types (Crunelli and Leresche, 2002b; Guerrini and Noebels,
2014) and the outcome of monotherapy (Glauser et al.,
2013; Shinnar et al., 2017). Indeed, the different location of
the pre-ictal changes of cortical BOLD amplitude in various
children with absence seizures (Bai et al., 2010, 2011;
Moeller et al., 2010) suggests that a diverse genotype may
bring about cellular and synaptic alterations preferentially in
different cortical networks, a possibility that can be directly
tested by large studies of combined functional MRI, EEG
and/or MEG of affected individuals with a known genotype.
Third, the existence of a CIN settles the long-standing con-
troversy about cortex or thalamus initiation of absence seiz-
ures (Avoli, 2012) in favour of the cortex, but is entirely
compatible with the results of many experimental studies
since the 1940s showing the emergence of SWD or absence
seizures following various means of activation of different
thalamic regions in normal (i.e. non-epileptic) animals
(Avoli, 2012; Lu¨ttjohann and Van Luijtelaar, 2015; Taylor
and Crunelli, 2014; Sorokin et al., 2017). That small local-
ized changes in neuronal excitability limited to a restricted
cortical or thalamic region can prompt generalized SWD-like
activity throughout cortico-thalamo-cortical networks sug-
gests that these networks are naturally susceptible to such
paroxysmal oscillations, as indicated by the expression of
absence seizures in normal mice following knockout of a sin-
gle gene (Cacna1a, coding for P/Q-type Ca2+ channels) se-
lectively in layer 6 pyramidal neurons (Bomben et al., 2016)
and the expression of short-duration SWDs in non-epileptic
and wild-caught rodents (Taylor et al., 2017, 2019).
Fourth, whereas the above data provide novel insights on
absence seizure initiation, there is currently no evidence as to
which cortical and thalamic regions (or indeed other brain
areas) are crucial for SWD generalization. Many studies in
young and adult cohorts with absence seizures indicate the
critical involvement of the thalamus in the expression of
these seizures (Moeller et al., 2008, 2009, 2010, 2013;
Tyvaert et al., 2009; Tenney et al., 2013). Notable in this
respect is the observation that in GAERS rats very brief
(51 s), small amplitude SWD that are present in the cortex
but not in the thalamus are not accompanied by any overt
behavioural sign, i.e. no absence seizure occurs (Polack
et al., 2007), suggesting that thalamic recruitment might be
a key step for generalization. If so, thalamic higher order
and intralaminar nuclei with their wide cortical innervation
(Jones, 2003; Giber et al., 2015) might be the critical thal-
amic region(s). In particular, the rodent thalamic posterior
nucleus, roughly equivalent to the anterior pulvinar region
in humans (Jones, 2003), may be one of the key hubs for
absence seizure generalization in view of (i) its critical in-
volvement in pre- and post-ictal activity (Lu¨ttjohann et al.,
2013; Lu¨ttjohann and Van Luijtelaar, 2015; Sysoeva et al.,
2016b) and at the onset and offset of SWD (Lu¨ttjohann and
Pape, 2019); and (ii) the ability of its stimulation to induce a
stronger and longer-lasting excitation of cortical layer 2/3
neurons compared to the activation of other thalamic nuclei
(Zhang and Bruno, 2019).
Absence seizure ictogenesis
Our understanding of absence seizure ictogenesis has been
dominated for 25 years by the results of brain slice studies,
which suggested that hyperexcitability of the glutamatergic
thalamocortical and the GABAergic reticular thalamic
(NRT) neurons through their bursts of action potentials
mediated by T-type Ca2+ channels (T-channels) at each par-
oxysmal cycle of a SWD form the rhythmogenic network
mechanism of absence seizures (von Krosigk et al., 1993;
Bal et al., 1995a, b; McCormick and Contreras, 2001)
(Fig. 3A). Strong firing at each paroxysmal cycle is also pre-
sent in NRT neurons and excitatory cortico-thalamic and in-
hibitory neurons of the CIN in animal models under
anaesthesia (with either urethane, ketamine, fentanyl or fen-
tanyl + antipsychotic) (Slaght et al., 2002; Polack et al.,
2007; Chipaux et al., 2011; Williams et al., 2016), though
under this experimental condition many thalamocortical
neurons do not express T-channel-mediated bursts of action
potentials and could, in fact, be electrically silent during
many paroxysmal cycles within a SWD (Steriade and
Contreras, 1995; Pinault et al., 1998, 2006) (Fig. 3B).
Recent evidence
Applying electrical recordings and calcium imaging of large
neuronal ensembles to freely moving and head-restrained
non-anaesthetized animals, respectively, two recent studies
(McCafferty et al., 2018b; Meyer et al., 2018) have for the
first time characterized with single-cell resolution the icto-
genic network activity that takes place in cortex and thal-
amus during absence seizures in three models: a polygenic
model (the GAERS rat), a monogenic model (the stargazer
mouse) (Noebels et al., 1990) and the pharmacological GHB
model in rats.
The first common discovery of both studies is that the vast
majority of cortico-thalamic and thalamocortical neurons do
not increase their total firing rate during a seizure but ex-
hibit either a decrease or no change, with single neurons of
both neuronal populations showing electrical silence at
many SWD cycles [Fig. 3C(i, ii, iv) and 4A] (McCafferty
et al., 2018b; Meyer et al., 2018). When they do fire, they
elicit either a single spike or a burst of action potentials in
synchrony with the SWD spike.
The second key and common finding is that cortico-thal-
amic, thalamocortical and NRT neurons are not hard-wired
to either prevalently express electrical silence, bursts, or sin-
gle action potential firing but can switch from one pattern to
the others in successive paroxysmal cycles and seizures, with
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some neurons being mostly silent during one seizure but
very active in subsequent ones (see Supplementary Fig. 5 in
McCafferty et al., 2018b) (Meyer et al., 2018). Nevertheless,
both cortex and thalamus consistently receive a robust EEG-
spike-correlated barrage of action potentials from the other
region at each and every SWD cycle see enlarged single cells
and population activity in Fig. 3C(i)] (McCafferty et al.,
2018b), indicating that ictal cortical and thalamic outputs
are a population activity, as originally suggested by Buzsa´ki
(1991) for thalamocortical neurons. In this respect, an im-
portant finding that has often been overlooked or misinter-
preted is that, while the firing in the somatosensory cortex
leads that of the somatosensory thalamus in the first 500 ms
of a seizure (i.e. in the first three to four paroxysmal cycles
in rodents), the activity of thalamic neurons may precede
that of cortical neurons or vice versa during subsequent
cycles (Meeren et al., 2002): i.e. once a seizure is fully gener-
alized, either of these two regions may, in different paroxys-
mal cycles within a seizure, take a temporally leading role in
reinforcing firing in the other. Thus, the average timing of
the ictal firing of cortico-thalamic and thalamocortical neu-
rons (of different thalamic nuclei) within a paroxysmal cycle
greatly overlaps, as does that of NRT neurons (Fig. 4B).
The third common and unexpected result is that cortical,
thalamocortical and NRT neurons markedly decrease their
total firing 2–3 s before a SWD can be detected in the
EEG (Fig. 4A) (McCafferty et al., 2018b; Meyer et al.,
2018). In contrast, T-channel-mediated burst firing shows a
steep increase that begins 0.5–1.0 s before seizure onset,
peaks just few tens of milliseconds and 2.5 s after seizure
onset in ventrobasal thalamocortical neurons and NRT neu-
rons, respectively, and is maintained until seizure termin-
ation (Fig. 4A) (McCafferty et al., 2018b). While at present
we do not know the mechanism underlying this pre-ictal re-
duction in cortical firing, the pre-ictal decrease in thalamo-
cortical and NRT neuron firing might result from the
reduced activity of layer 5/6 cortico-thalamic neurons
(Fig. 4A). An alternative cause may the increased inhibitory
Figure 3 Absence seizure ictogenesis in cortico-thalamo-cortical networks. (A) In thalamic slices, glutamatergic thalamocortical (TC)
neurons and GABAergic reticular thalamic (NRT) neurons elicit a T-type Ca2 + channel-mediated burst of action potentials at each cycle of the
putative paroxysmal activity. (B) In anaesthetized absence seizure models, except TC neurons that fire rarely, all other constituent neurons of
cortico-thalamo-cortical networks—cortical regular-spiking excitatory pyramidal neurons (RS), cortical fast-spiking inhibitory neurons (FS) and
NRT neurons—show strong (mostly burst) firing at each cycle of a SWD. (C) In sharp contrast, in awake animal models, RS neurons [C(ii)] show
a marked ictal decrease of firing (bottom trace is an intracellular recording). The vast majority of TC neurons decrease their firing rate during seiz-
ures [raster plot in C(i)] though there is a consistent output at each cycle of the SWD when the firing of these neurons is grouped together [see
enlarged population activity in C(i)]. Two groups of NRT neurons can be distinguished on the basis of their ictal firing: one group that increases
their firing ictally (mostly consisting of T-type Ca2 + channel-mediated bursts of action potentials) [top three cells in the raster plot in C (iii)] and
another group that shows a decreased activity [bottom three cells in the raster plot in C(iii)]. [C(iv)] Histograms of the activity of NRT neurons
recorded simultaneously with an RS (top) or and a TC neuron (bottom) in a freely moving absence seizure model. Note how, in contrast to results
in thalamic slices (A), the ictal NRT neuron firing (green bars) is mainly driven by the cortical RS neuron spikes rather than the TC neuron spikes.
Time zero marks the firing of the RS and TC neurons (red and blue line, respectively). Modified from Bal et al. (1995b); Pinault et al. (1998);
Polack et al. (2007); Chipaux et al. (2011); McCafferty et al. (2018b) and Meyer et al. (2018).
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input from a common source, such as the GABAergic neu-
rons of the substantia nigra pars reticulata (SNr), which are
known to innervate both NRT neurons and thalamocortical
neurons of many first and higher-order thalamic nuclei (Ray
and Price, 1992; Miyamoto and Jinnai, 1994; Sakai et al.,
1998; Franc¸ois et al., 2002; Cebria´n et al., 2005). However,
while SNr neurons do markedly increase their firing during
absence seizure in freely moving rats (Deransart et al., 2003)
(see ‘Essential control of absence seizure by the basal gan-
glia’ section), it remains to be demonstrated whether such
enhancement occurs before seizure onset.
In contrast to cortico-thalamic and thalamocortical neu-
rons, NRT neurons in the intact brain of non-anaesthetized
models fire at almost each SWD cycle [Fig. 3C(iii)] and
show an increase in their ictal total firing compared to inter-
ictal periods (Fig. 4A) (McCafferty et al., 2018b). Moreover,
in contrast to the results in vitro (von Krosigk et al., 1993;
Bal et al., 1995a, b; Huntsman et al., 1999; McCormick and
Contreras, 2001; Sohal et al., 2003) and under anaesthesia
(Slaght et al., 2002), two populations of NRT neurons can
be detected in freely moving models: one that preferentially
fires T-channel bursts in successive cycles, while the other
Figure 4 Pre-ictal and ictal temporal firing dynamics of absence seizures. (A) Average fluorescence changes indicate a decrease in fir-
ing in unidentified cortical layer 5 and 6 (but not layer 4) neurons of the visual cortex of non-anaesthetized, head-restrained stargazer mice that
begins more than 2 s before and ends almost 2 s after the electrographic seizure. A similar decrease in total firing rate that start 2 s before seizure
onset and terminates at seizure offset also occurs in identified fast-spiking (FS) interneurons of the cortical initiation network (CIN) and in ventro-
basal thalamocortical (TC) neurons (blue trace) of freely moving GAERS rats, whereas the total firing GABAergic thalamic reticular neurons (green
trace) decreases from 3 s before seizure onset but then show a persistent ictal increase until seizure offset. In contrast, there is an increase in
T-channel mediated burst firing in ventrobasal thalamocortical (blue) and thalamic reticular neurons (green) neurons that begins 1 s prior to seiz-
ure onset and continues until seizure offset. (B) Timing of action potential output with respect to the EEG-spike of different neurons in cortico-
thalamo-cortical and basal ganglia pathways are superimposed on a schematic spike-and-wave (light black line). Time zero indicates the peak of the
EEG spike and individual brain regions are shown on the right. Data for cortico-thalamic CIN layer 5/6, substantia nigra, ventrobasal thalamocorti-
cal and reticular nucleus are from freely moving GAERS rats (Deransart et al., 2003; McCafferty et al., 2018b), whereas data from striatum, subthala-
mic nucleus, and globus pallidus are from GAERS rats under neurolept anaesthesia (Slaght et al., 2004; Paz et al., 2005, 2007). As the firing time of
cortico-thalamic layer 5/6 neurons in the CIN of freely moving GAERS rats occurs about 10 ms earlier than that of the same GAERS neurons
recorded under neurolept anaesthesia, the timing of cortico-subthalamic, cortico-striatal, cortico-thalamic CIN layer 2/3 and layer 4 neurons taken
from GAERS under neurolept anaesthesia were modified accordingly. FS-INT = fast-spiking GABAergic interneurons; MSN = striatal medium
spiny neurons. Open and filled symbols indicate inhibitory GABAergic and excitatory glutamatergic neurons, respectively. (A) Data for CIN FS
interneurons are unpublished observations, the others were modified from McCafferty et al. (2018b) and Meyer et al. (2018).
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fires mostly tonic spikes relatively asynchronously [see top
three and bottom four neurons, respectively, in Fig.
3C(iii)], with the former group showing a higher coherence
with SWD in the EEG (McCafferty et al., 2018b). Whether
these two groups may be related to the rostral and caudal
sectors of the NRT that have different contributions to ab-
sence seizure in genetic models (Aker et al., 2006; Meeren
et al., 2009) or to the chemically-distinct populations of
NRT neurons that show different bursting activity in nor-
mal non-epileptic animals (Halassa et al., 2014) remains to
be elucidated. Moreover, in contrast to the prevailing view
(von Krosigk et al., 1993; Bal et al., 1995a,b; Huntsman
et al., 1999; McCormick and Contreras, 2001), the ictal
firing of NRT neurons in freely moving animals is driven
by cortical and not thalamocortical neuron activity
[Fig. 3C(iv)]: i.e. the NRT-mediated ictal inhibition of tha-
lamocortical neurons is of a feed-forward and not a feed-
back nature.
T-type Ca2 + calcium channels and absence seizures
Another key finding of McCafferty et al. (2018b) is
that T-channel bursts of cortical and NRT neurons are
critically involved in the ictal synaptic interactions with
thalamocortical neurons, whereas T-channel bursts of tha-
lamocortical neurons do not play a role in the ictal interac-
tions of these neurons with both cortical and NRT
neurons. Indeed, localized injection of TTA-P2, a potent
and selective pan-T-channel antagonist (Shipe et al., 2008;
Dreyfus et al., 2010), by McCafferty et al. (2018b) shows
that the block of T-channels in the NRT and CIN of
GAERS rats drastically decreases absence seizures (see also
Avanzini et al., 1992), whereas blocking T-channels in tha-
lamocortical neurons of the ventrobasal thalamus, one of
the somatotopic thalamic nuclei of the GAERS CIN, has
no effect on absence seizures (Fig. 5), the rhythmicity of
the thalamic output and its synchrony with the SWD
spike. Thus, the use of TTA-P2 to provide a fast block of
T-channel function without compensatory activities shows
that T-channels of ventrobasal thalamocortical neurons
(i.e. Cav3.1) are not essential for spontaneous absence seiz-
ures in GAERS rats whereas those of the CIN (i.e. Cav3.1,
Cav3.2 and Cav3.3) and NRT (i.e Cav3.2 and Cav3.3) are
(Fig. 5).
This critical role of T-channels of cortical and NRT, but
not thalamocortical neurons in experimental absence seiz-
ures is compatible with the gain-of-function mutations of the
Cav3.2 subtype of T-channels reported in some children
with absence seizures (Chen et al., 2003; Khosravani et al.,
2004) and in GAERS rats (Talley et al., 2000; Powell et al.,
2009; Cain et al., 2018), as this subtype of T-channels is
expressed in cortical and NRT neurons but not in thalamo-
cortical neurons (Fig. 5) (Talley et al., 1999). Indeed, select-
ive expression of human Cav3.2 (C456S) mutant channels in
the barrel cortex of normal mice does elicit absence seizures
(Wang et al., 2015), and in vivo knockdown of Cav3.2 in
GAERS NRT neurons markedly decreases absence seizures
(Cain et al., 2018). Moreover, the lack of an essential
role for Cav3.1 subtype of T-channels of ventrobasal thala-
mocortical neurons in absence seizures of GAERS rats
(McCafferty et al., 2018b) is compatible with the expression
of absence seizure in PLCb4 knockout mice with increased
L-type and Cav3.1 channel function (Cheong et al., 2009).
This prior study, in fact, did not distinguish between L-type
and Cav3.1 channels as it used mibefradil, a non-specific
blocker of Na+ , ATP-sensitive K+ , L-type Ca2+ and T-type
Ca2+ channels (Mishra and Hermsmeyer, 1994;
Bezprozvanny and Tsien, 1995; Nilius et al., 1997; Viana
et al., 1997; Gomora et al., 1999; Liu et al., 1999).
Significance of new evidence
A number of important issues derive from the novel find-
ings outlined above. First, the emerging picture from the
investigations conducted in the absence of anaesthesia sug-
gests that, rather than an exclusively thalamic rhythmo-
genesis, cortical mechanisms are key in driving absence
seizures and determining SWD frequency. In particular,
the synchronous output of thalamocortical neurons is not
determined by the dynamics of their T-channel-mediated
burst firing but rather is driven by top-down cortical exci-
tation and sharpened by cortically driven, i.e. feed-for-
ward, NRT inhibition, with both the cortically-driven
excitation and the NRT inhibition critically depending on
T-channel bursts (McCafferty et al., 2018b). Notably, the
key role of a cortical drive in absence seizure ictogenesis
had been predicted by studies in thalamic slices with an ar-
tificially-generated cortical feed-back (Bal et al., 2000;
Blumenfeld and McCormick, 2000).
Second, as during absence seizure all thalamic neurons
are strongly driven by the excitatory cortical afferent activ-
ity, why do thalamocortical neurons show a decrease in
ictal firing? The most likely explanation is that the stron-
ger cortico-NRT neuron synapses (compared to cortico-
thalamocortical neuron synapses) (Contreras et al., 1993;
Golshani et al., 2001) and the robust NMDA-mediated
drive of NRT neuron bursts (Lacey et al., 2012; Wang
et al., 2015) assure a strong rhythmic inhibition of thala-
mocortical neurons that overcomes the cortically driven
ictal excitation and thus restrict the output of thalamocort-
ical neurons within a narrow temporal window around the
EEG spike (Fig. 4B) (McCafferty et al., 2018b). Notably,
the NRT-mediated inhibition of thalamocortical neurons is
strengthened by the increased ictal firing of the GABAergic
SNr neurons that is also phase-locked to the SWD-spike
(Fig. 6) (see ‘Essential control of absence seizure by the
basal ganglia’ section).
Third, the ictal decrease in the correlation of neuronal ac-
tivity among visual cortex neurons compared to interictal
periods in stargazer mice (Meyer et al., 2018) is, on the one
hand, surprising, as it leaves unexplained the origin of the
EEG spikes that are present in the same cortical region. On
the other hand, this decreased correlation may underlie the
decreased ictal BOLD signal synchrony observed in the ‘oc-
cipital cortical network’ of individuals with generalized
SWD and absence seizures (Tangwiriyasakul et al., 2018)
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(Fig. 2B) and the deficits in visual tasks often reported as
comorbid condition of absence seizure (see ‘absence seizure
neuropsychiatric comorbidity’ section).
Fourth, the relative paucity of the firing of cortical and
thalamic neurons and their variable recruitment between
subsequent cycles within a seizure and between seizures in
non-anaesthetized animal models is in sharp contrast with
the results of in vitro studies in cortical and thalamic slices
and in vivo investigations under anaesthesia (Fig. 3). This
conclusively demonstrates that absence seizure ictogenesis is
not fully recapitulated either by anaesthetized models (with-
out behaviour, with altered arousal and excitability, and
often under the influence of a neuromuscular blocking drug)
and by cortical or thalamic slices (in which reciprocal cor-
tico-thalamic and thalamo-cortical connectivity are absent
and the membrane potential deviates from that in the awake
intact brain). Thus, isolated cortical and thalamic slices are
of limited use when investigating the paroxysmal firing dy-
namics of SWD and care should be taken in the interpret-
ation of firing patterns and temporal dynamics obtained
under anaesthetized conditions. Nevertheless, isolated brain
slices (from cortex, thalamus or other brain regions) still
offer the opportunity to characterize the constitutive bio-
physical abnormalities of the voltage- and transmitter-gated
channels of genetic absence seizure models or transfected
human mutant channels.
Essential control of absence
seizures by the basal ganglia
Since the original observation of the anti-absence effect of
blocking SNr neuron activity by local injection of muscimol,
a GABA-A receptor agonist, in freely moving GAERS rats
(Depaulis et al., 1988a, b), many investigations using local-
ized and selective pharmacological manipulations in this
brain region, the striatum and the subthalamic nucleus have
demonstrated that both the direct and indirect basal ganglia
pathways exert a tight control over absence seizures in dif-
ferent freely behaving genetic and pharmacological models
(Depaulis et al., 1989; Deransart et al., 1996, 2000, 2001;
Vercueil et al., 1998). Notably, the involvement of the basal
ganglia in absence seizures is supported by the consistent
finding of ictal changes in functional MRI BOLD signals in
the basal ganglia of CAE and adult cohorts with absence
seizure (Li et al., 2009; Bai et al., 2010; Berman et al., 2010;
Luo et al., 2011).
The patterns and temporal dynamics of the ictal firing of
morphologically and electrophysiologically identified neu-
rons of all basal ganglia nuclei have been thoroughly investi-
gated (Slaght et al., 2004; Paz et al., 2005, 2007) and are
illustrated in Figs 4B and 6. The ictal activity of cortico-stri-
atal neurons consists of rhythmic depolarizations with most-
ly single action potential that are phase-locked to the SWD
Figure 5 T-type Ca2 + channels in cortex and nucleus reticularis thalami (NRT) are necessary for absence seizures. Schematic
representation of injection sites with their complement of T-channel subtypes (left) and original data (right) showing the ability of the potent and
selective pan T-type Ca2 + channel antagonist, TTA-P2, to block absence seizures in GAERS rats when bilaterally injected by microdialysis in the
CIN (top row) or the NRT (middle row). Similar administration in the ventrobasal (VB) thalamic nucleus (one of the somatotopic thalamic nuclei of
the CIN in this animal model) that contains only thalamocortical neurons, has no effect on absence seizures (bottom row).
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spike. In the striatum, the fast-spiking GABAergic interneur-
ons show short (two to four spikes) high frequency (300–
400 Hz) bursts during absence seizures, and thus the striatal
output neurons, the GABAergic medium spiny neurons, do
not fire ictally but only exhibit large rhythmic subthreshold
depolarizations (Slaght et al., 2004). In contrast to cortico-
striatal and cortico-thalamic neurons, the cortico-subthala-
mic neurons show robust firing in two distinct periods, one
well before and one around the EEG spike (Paz et al.,
2005). This double wave of excitation leads the excitatory
subthalamic neurons to have a characteristic temporal pro-
file consisting of a single action potential (well before the
SWD spike), which is followed by a short period of silence
and then a high frequency burst of action potentials around
the SWD spike (Paz et al., 2005). Thus, the output of the
basal ganglia to the thalamus, i.e. the firing of the
GABAergic SNr neurons, is increased during absence seiz-
ures (Deransart et al., 2003) as a result of the combined ef-
fect of (i) the ictal electrical silence of the GABAergic striatal
medium spiny neurons (Slaght et al., 2004); and (ii) the
increased ictal firing of the glutamatergic subthalamic neu-
rons (Fig. 6) (Paz et al., 2005). Notably, all these studies
were carried out in GAERS rats and, except the one in the
SNr (Deransart et al., 2003), performed under neurolept an-
aesthesia. Thus, since the firing of both cortico-thalamic,
thalamocortical and NRT neurons show subtle but key dif-
ferences when recorded under this anaesthetic regime and in
freely moving animals (see previous section and Fig. 3), it
Figure 6 Ictogenic firing of basal ganglia neurons. Schematic diagram of the ictal activity of the component neurons of the direct and indir-
ect basal ganglia pathways recorded under neurolept anaesthesia (except the substantia nigra neurons) are illustrated close to the morphological
representation of each neuronal type. Electrical activity of fast-spiking striatal interneurons and substantia nigra and subthalamic neurons shows
extracellular recordings, the others are intracellular recordings. The excitatory and inhibitory nature of the synaptic connections is indicated by
encircled plus and minus symbols. The relative size of the morphological reconstructions has been altered for graphical purposes. See text for
additional details. Modified from Deransart et al. (2003); Slaght et al. (2004) and Paz et al. (2005, 2007).
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would be important to investigate the activity of the various
neuronal populations of the basal ganglia under the latter
experimental condition and in other animal models.
A recent study on STXBP1, a gene encoding the presynap-
tic protein Munc18-1, shows that injection of muscimol in
the striatum of Stxbp1–/– mice blocks their short (0.5–2 s)
ethosuximide-sensitive absence seizures (Miyamoto et al.,
2019). Moreover, striatal application of NASPM, a selective
blocker of calcium-permeable AMPA receptors, which are
more abundant in the fast-spiking striatal interneurons than
in the striatal medium spiny neurons (Deng et al., 2007),
elicits absence seizures in wild-type mice and (continuous)
activation of Designer Receptor Exclusively Activated by
Designer Drugs (DREADDS)-transfected fast-spiking striatal
interneurons markedly reduces ASs in Stxbp+ /– mice
(Miyamoto et al., 2019). These pharmacological and phar-
maco-genetic results directly demonstrate a key role for the
striatum in the control of absence seizures but are not sup-
ported by the lack of changes in the ictal firing of putative
striatal fast-spiking and medium spiny neurons. Indeed, the
latter result and other findings of Miyamoto et al. (2019)
are in contrast with previous observations in morphological
identified striatal neurons of GAERS rats (see above) (Fig. 6)
(Slaght et al., 2004). It could be that different populations of
striatal neurons have a differential sensitivity to these drugs
because in monkeys there is evidence of a diverse activation
of encephalin-, parvalbumin- and substance P-containing
striatal neurons of the direct and indirect basal ganglia path-
ways following different stimulation paradigms of cortico-
striatal neurons in the sensorimotor cortex (Parthasarathy
and Graybiel, 1997). Thus, further studies using selective
manipulations for either the direct or the indirect basal gan-
glia pathways are required to fully clarify the pro- or anti-
absence contribution that the DRD1- and DRD2-containing
striatal medium spiny neurons and various striatal inter-
neuron populations may make to absence seizure.
Enhanced inhibition of
thalamocortical neurons: a key
ictogenic feature of absence
seizures
The essential control of absence seizures by the SNr
(Depaulis et al., 1988a, b, 1989; Deransart et al., 1996,
2001) implies a causal role for the increased firing of its out-
put neurons in absence seizure generation and thus for an
enhanced ictal GABAergic inhibition of thalamocortical neu-
rons of the ventromedial, ventrolateral and ventrobasal nu-
clei as well as the many other thalamic regions, including the
limbic thalamus and intralaminar thalamic nuclei, that are
innervated by the SNr (Ray and Price, 1992; Miyamoto and
Jinnai, 1994; Sakai et al., 1998; Franc¸ois et al., 2002;
Cebria´n et al., 2005). Notably, recent findings have shown a
direct excitatory connection from the substantia nigra to the
NRT (Antal et al., 2014), which will undoubtedly add to the
ictal cortical excitation of these thalamic GABAergic neurons
whose axons are known to cover almost the entire thalamus
(Pinault, 2004). Thus, two separate sources of increased ictal
GABAergic inhibition, one from the SNr and one from the
NRT, engulf thalamocortical neurons of the majority of
thalamic nuclei during absence seizure, providing (i) a tight
temporal control of the ictal firing of these neurons via acti-
vation of synaptic GABA-A receptors, i.e. phasic GABA-A
inhibition (Fig. 4B) (McCafferty et al., 2018b); and (ii) a per-
sistent decrease in excitability, via activation of extra-synap-
tic GABA-A receptors, i.e. tonic GABA-A inhibition (Cope
et al., 2005). This ictal increase in the inhibition of thalamo-
cortical neurons markedly contributes to the overall decrease
in total firing, the paucity of single action potential firing
and the increased T-channel-mediated burst firing during ab-
sence seizures (Figs 3 and 4A). Within these similarities,
however, thalamocortical neurons in the ventrobasal, ventro-
medial and ventrolateral nuclei do show slightly different
ictal firing features (Figs 3 and 6) (Pinault et al., 1998; Paz
et al., 2007; McCafferty et al., 2018b). Thus, as different
classes of layer 5/6 output neurons, i.e. cortico-thalamic, cor-
tico-striatal and cortico-subthalamic neurons, show different
ictal firing patterns (Figs 3 and 6), so do thalamocortical
neurons in different thalamic nuclei. Though the precise rea-
sons for these differences still remain to be fully elucidated,
three possibilities might be considered. First, in contrast to
the accepted view the posterior thalamus, but not the ventro-
basal nucleus, receives not only inhibitory but also direct ex-
citatory connections from the substantia nigra (Antal et al.,
2014). Thus, it may be possible that the balance between
SNr-derived inhibition and excitation plays a role in the dif-
ferent ictal firing observed in thalamocortical neurons of the
posterior nucleus and other thalamic nuclei. Second, there
could be a differential modulation by DRD1 and DRD2
receptors of the tonic GABA-A inhibition in thalamocortical
neurons of different thalamic nuclei (Connelly et al., 2013a,
b; Yague et al., 2013). Third, the involvement of GABA-B
receptors, including the generation of GABA-B receptor-
mediated synaptic potentials (Crunelli et al., 1988; Crunelli
and Leresche, 1991; Charpier et al., 1999), their direct
modulation of extra-synaptic GABA-A receptors (Connelly
et al., 2013a, b), the regulation of transmitter release via
presynaptic GABA-B receptors (Gervasi et al., 2003; Bessaih
et al., 2006) and the direct activation of GABA-B receptors
of thalamic astrocytes (Gould et al., 2014), may be different
in various thalamic regions.
Notably, in some mouse and rat genetic models of absence
seizure, including the GAERS rats and the stargazer mice,
the combined NRT- and SNr-derived ictal increase in
GABAergic inhibition of thalamocortical neurons may be
enhanced by the loss-of-function of the astrocytic GABA
transporter GAT-1 (but not GAT-3) (Cope et al., 2009;
Pirttimaki et al., 2013), providing additional restraints to the
thalamocortical neuron firing. Notably, since there is only a
silent mutation in SLC6A1 (the gene encoding GAT-1) in
these two absence seizure models (Cope et al., 2009), their
GAT-1 loss-of-function might be due to its aberrant intracel-
lular transport, misplaced location around the synaptic cleft,
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alteration in phosphorylation states or inefficient modulation
by various endogenous signalling molecules (Beckman et al.,
1999; Venderova et al., 2005; Vaz et al., 2011). Both in
GAERS rats and stargazer mice, this GAT-1 loss of function
leads to constitutively higher GABA levels in the thalamus,
but not somatosensory cortex (Richards et al., 1995) and an
increased basal tonic GABA-A inhibition in thalamocortical
neurons (Cope et al., 2009; Errington et al., 2011a). Indeed,
enhanced tonic inhibition in ventrobasal thalamocortical
neurons is sufficient to elicit absence seizure in normal mice
and rats and is necessary for the expression of absence seiz-
ure in the abovementioned models as well as in the GHB
and other models (Cope et al., 2009; Errington et al.,
2011b). These results in animal models are corroborated by
the following findings in humans: (i) higher GABA levels
were observed in ipsilateral thalamus, but not cortex, of a
child with atypical unilateral SWD (Leal et al., 2016);
(ii) anti-epileptic drugs that increase GABA levels, such as
tiagabine and vigabatrin, aggravate or induce absence seiz-
ures and are contraindicated in individuals with absence
seizures (Perucca et al., 1998; Ettinger et al., 1999;
Panayiotopoulos, 1999); (iii) the vast majority of currently
known human mutations in SLC6A1 lead to a GAT-1 loss-
of-function (Mattison et al., 2018); and (iv) absence seizures
are by far the most common epileptic phenotype in children
with SLC6A1 mutations (Dikow et al., 2014; Johannesen
et al., 2018).
In summary, solid experimental and clinical evidence
strongly suggest that, in contrast to the classical view that
absence seizures are driven by increased excitation and/or
decreased inhibition in all brain regions involved in the par-
oxysmal activity, the ictogenic thalamic mechanism of ab-
sence seizure is uniquely shaped by the enhanced GABAergic
inhibition of thalamocortical neurons that derives both from
intra-thalamic (NRT), and extra-thalamic (SNr) sources.
Whether other sources of thalamic GABAergic inhibition
(i.e. zona incerta, anterior pretectal nucleus) (Giber et al.,
2008) participate in the ictal increase of thalamocortical neu-
ron inhibition is currently unknown. In some absence seizure
models and children with absence seizure, this increased ictal
inhibition of thalamocortical neurons is enhanced by the
loss-of-function of GAT-1, which does not always result
from a genetic mutation of this transporter gene. Whether a
similarly increased inhibition and GAT-1 loss-of-function
also shape the ictogenic mechanisms of excitatory and in-
hibitory neurons within cortical and basal ganglia networks
remains to be established.
Pharmaco-resistance of absence
seizure: recognizing the problem
For many years now, the pharmacological therapy of ab-
sence seizures of different epilepsies, and in particular of
CAE, juvenile absence epilepsy and juvenile myoclonic epi-
lepsy, has mostly relied on ethosuximide, valproic acid,
lamotrigine or any of their combinations (Penovich and
Willmore, 2009). In 2013, Glauser et al. published the
results of the first large (446 newly diagnosed) double-blind
randomized controlled trial in a pure CAE cohort that com-
pared the efficacy and tolerability of the above medications.
This study shows that at 12 months the freedom-from-fail-
ure rate for monotherapy with either ethosuximide or val-
proic acid is similar (45%) and much higher than that for
lamotrigine (21%) (Fig. 7). Surprisingly, children who had
longer seizures before the start of the pharmacological ther-
apy were more likely to achieve seizure-freedom, a result
that did not depend on the type of anti-absence drug used
(Dlugos et al., 2013). Notably, children receiving valproic
acid performed substantially worse in tests for attention
than those receiving ethosuximide or lamotrigine (see
below), and 42% of all children who discontinued the treat-
ment because of adverse events were receiving valproic acid.
Later, the same authors used their well-characterized large
cohort to examine the clinical response to a second mono-
therapy in children experiencing failure of the initial treat-
ment (Cnaan et al., 2017). After 1 year, 49% of children
were seizure-free with a higher proportion receiving ethosux-
imide or valproic acid (57% or 49%, respectively) than
lamotrigine (36%) (Fig. 7). The superior efficacy of ethosux-
imide over lamotrigine as initial monotherapy and the pres-
ence of fewer cognitive and behavioural adverse effects than
valproic acid have been confirmed by another recent study
(Shinnar et al., 2017) and by analysis of a prospective obser-
vational cohort that found better long-term (55 and 510
years) outcomes (i.e. seizure- and medication-free) in chil-
dren initially treated with ethosuximide (76% and 76%
complete remission, respectively) than with valproic acid
(39% and 44%, respectively) (Berg et al., 2014).
In summary, the serious implications of these studies are
that (i) in contrast to prevailing views ‘appropriately chosen
and used antiepileptic drugs’ (the ILAE criterion for drug-
resistant epilepsy) (Kwan et al., 2009) leave 30% of chil-
dren with uncontrolled absence seizures; and (ii) there are
strong neuropsychiatric adverse effects associated with val-
proic acid treatment, a critical factor to be considered when
selecting the first monotherapy in paediatric and juvenile
populations with absence seizures.
Neuropsychiatric comorbidities of
absence seizures
Studies in humans
It is only relatively recently that the full extent of the psychi-
atric comorbid conditions that accompany absence seizures
has been investigated, though clear warnings were available
since the early 1960s from studies of mixed-age mixed-
epilepsy populations with generalized SWD, mostly under
pharmacological therapy (Hertoft, 1963; Ounsted et al.,
1963; Loiseau et al., 1983; Wirrell et al., 1997; Aldenkamp
et al., 2001; Ott et al., 2001; Henkin et al., 2005; Vanasse
et al., 2005). The unpromising picture that emerges from re-
cent investigations shows that 60% of children with CAE
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have neuropsychiatric comorbidities, with attention deficits
as the most common comorbidity (35–40%), followed by
mood disorders (Caplan et al., 2008; Glauser et al., 2010;
Masur et al., 2013; Gencpinar et al., 2016; Lee et al., 2018)
(Fig. 8), in sharp contrast to the high prevalence of depres-
sion associated with convulsive seizures (Noebels, 2015b).
Notably, in the only study of a large (446 children) drug-
naı¨ve CAE cohort, the impairments in attention were not of
an ADHD type as they were ‘associated more with an in-
attentive than hyperactive form of attention deficit, i.e. loss
of focus on a task more than impulsivity of response’
(Masur et al., 2013), a result similar to that reported previ-
ously in a smaller cohort of children with absence seizures
and other idiopathic epilepsies (Hermann et al., 2007).
Moreover, though not always assessed in drug-naı¨ve popula-
tions, reductions of visual-related functions, including visual
memory and visuo-spatial tasks, have also been consistently
reported (Fedio and Mirsky, 1969; Jambaque´ et al., 1993;
Pavone et al., 2001; Nolan et al., 2004; Cheng et al., 2017),
a finding that may be linked to the recently reported de-
crease of interictal BOLD synchrony in the occipital cortex
of a CAE cohort (Tangwiriyasakul et al., 2018) and the lack
of ictal firing synchrony among visual cortical neurons in an
absence seizure model (Meyer et al., 2018).
The presence of neuropsychiatric deficits is comple-
mented by structural imaging data in cohorts with absence
seizures showing (i) smaller grey matter volume of brain
regions involved in attention (including orbital frontal
gyrus and temporal lobes) (Caplan et al., 2009); (ii)
smaller volume of the amygdala (a region linked to both
attention and anxiety/depression) (Schreibman Cohen
et al., 2009); (iii) altered age-related changes in cortical
thickness and sulcal depth (Tosun et al., 2011); and (iv)
diffusion tensor imaging abnormalities in default mode
network nodes (Qiu et al., 2016). Functional imaging evi-
dence of abnormalities in the default mode, dorsal atten-
tion and salience networks have also been reported
(Berman et al., 2010; Killory et al., 2011; Luo et al., 2014;
Li et al., 2015). Moreover, BOLD signal synchrony in
frontal and precuneus regions is altered ictally while that
in precentral areas and cingulum is affected both ictally
and interictally (Tangwiriyasakul et al., 2018) (Fig. 2B).
However, more than 90% of the children and adults
enrolled in all these structural and functional imaging
studies were on anti-absence medication for variable
lengths of time and no analysis of the drug effects as a
covariate was carried out: related confounds cannot, there-
fore, be discounted since the effect of anti-absence drugs
on both structural and functional brain imaging features
both in humans and animal models is unknown.
Psychiatric comorbid conditions, in particular attention
deficits, may precede the first absence seizure and the epi-
lepsy diagnosis (Hermann et al., 2007; Jones et al., 2007)
(Fig. 8). Whereas these results may suggest that the patho-
physiological abnormalities underlying absence seizure
comorbidities are at least partially independent from seiz-
ure occurrence, it is highly likely that the epileptogenesis
existing in presymptomatic children may also underlie
(and/or contribute to) their comorbid conditions (Fig. 8).
Moreover, attention deficits do persist even when seizures
are pharmacologically controlled (Williams et al., 2002;
Glauser et al., 2013; Masur et al., 2013), and notably
more children show this comorbidity after valproic acid
(49%) than ethosuximide (32%) and lamotrigine (24%)
monotherapy (Glauser et al., 2013). However, it remains
unclear whether the comorbidity observed after anti-
absence drug treatment is pre-existing, drug-induced and/
or due to lack of seizure control (Fig. 8, right). The mutual
causal interaction between epilepsy and comorbidity is a
very complex one in particular for epilepsies with a genetic
aetiology (Noebels, 2015b; Keezer et al., 2016): answering
the above question, therefore, is essential and will require
knowledge of the psychiatric effects of anti-absence drugs
in healthy individuals (and normal animals, see below),
which unfortunately are currently unknown (Loring et al.,
2007; Verrotti et al., 2018).
Figure 7 Pharmaco-resistance of absence seizures. The first 12-month-long monotherapy with either ethosuximide (ETX) or valproic
acid (VPA) is more effective than that with lamotrigine (LTG) in controlling absence seizures (left). Similar results are obtained when children un-
responsive to the initial monotherapy undergo a second 12-month-long monotherapy with a different drug (middle). The combined results of the
first and second monotherapy (right) show that about 30% of children with childhood absence epilepsy have pharmaco-resistant absence seizures.
Modified from Glauser et al. (2013) and Cnaan et al. (2017).
14 | BRAIN 2020: Page 14 of 28 V. Crunelli et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/brain/advance-article-abstract/doi/10.1093/brain/aw
aa072/5841645 by guest on 15 June 2020
Studies in animal models
Absence seizure models do show psychiatric comorbidities,
providing additional validity to these models and a means
for future mechanistic studies into these conditions. Subtle
alterations in attention, that may be task-specific, have been
reported in GAERS (Marques-Carneiro et al., 2016; Marks
et al., 2016a, b) and WAG/Rij rats (Karson et al., 2012;
Jafarian et al., 2015), but the majority of the animal studies
has focused on anxiety- and depression-like behaviours that
have been consistently observed in GAERS (Jones et al.,
2008; Bouilleret et al., 2009, Powell et al., 2009, 2014a, b;
Tringham et al., 2012; Dezsi et al., 2013; Marques-Carneiro
et al., 2014) and WAG/Rij rats (Sarkisova et al., 2010;
Russo et al., 2011; van Luijtelaar et al., 2013; Moyanova
et al., 2018). Notably, anxiety and absence seizures in
GAERS rats can be reduced by environmental enrichment
and these anxiolytic and anti-epileptogenic effects are herit-
able into the next generation (Dezsi et al., 2016), prompting
future investigations on potential epigenetic contributions to
human absence seizures and their comorbidity. Moreover,
rearing off-spring of WAG/Rij rats by non-epileptic Wistar
mothers from the second postnatal day results in a marked
decrease of absence seizures in early adulthood (Sitnikova
et al., 2016), suggesting that an increased maternal care and/
or a reduction in stressful environment early in development
may contribute to alleviate genetically determined absence
seizures.
Chronic (19 weeks) and acute administration of ethosuxi-
mide mitigate the anxiety-like phenotype in GAERS (Dezsi
et al., 2013), and anxiety and depression in SWD-expressing
Long-Evans rats (Shaw et al., 2009). In WAG/Rij rats,
chronic ethosuximide ameliorates depressive-like behaviour
(Sarkisova et al., 2010; van Luijtelaar et al., 2013) (but see
Russo et al., 2011). Notably, however, the abnormal phase-
amplitude coupling of EEG beta-gamma waves observed in
stargazer mice is unaffected by ethosuximide (Maheshwari
et al., 2017), indicating that aberrant cortical circuit-level dy-
namics persist even after seizure control. The pan-T-channel
blocker Z944 abolishes absence seizures, reduces aggressive
behaviour, rescues both recognition memory deficits (Marks
et al., 2016a) and sociability impairment (Henbid et al.,
2017), but increases anxiety-like behaviour in GAERS rats
(Marks et al., 2019). Thus, this potent and selective T-chan-
nel blocker controls absence seizures, but in contrast to the
weak and non-selective T-channels blocker ethosuximide
(Crunelli and Leresche, 2002a), it worsens anxiety-like be-
haviour, at least in GAERS rats. Finally, chronic lamotrigine,
which is the least effective absence seizure monotherapy in
humans (Glauser et al., 2013; Cnaan et al., 2017), blocks
absence seizures and ameliorates comorbid anxiety- and
Figure 8 Neuropsychiatric comorbidities of absence seizures. Attention deficits are the most common psychiatric comorbidity of child-
hood absence epilepsy; they can be present in pre-symptomatic children and persist even when seizures are pharmacologically controlled. Other
cognitive impairments and mood disorders (e.g. anxiety, depression) may also be present. It is likely that the aberrant cortico-thalamo-cortical
networks underlying absence seizure combine with the abnormal basal ganglia-limbic-monoamine networks underlying cognitive impairments
and mood disorders to generate the overall neurological and neuropsychiatric phenotype of epilepsies with absence seizures (left column).
Interactions between these abnormal networks might contribute to a lower seizure threshold and an increased risk of comorbidity. Moreover,
absence seizures and anti-absence drugs may induce, or aggravate existing, comorbid conditions (right column). Solid and dashed blue lines repre-
sent established and putative links, respectively.
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depression-like phenotypes in Long-Evans rats (Huang et al.,
2012). Notably, no study has investigated whether anti-ab-
sence drugs induce psychiatric deficits in normal non-epilep-
tic (either young or adult) animals, except for one
investigation reporting negative effects of ethosuximide on
fear memory but not spatial learning (Ponnusamy and
Pradhan, 2006).
However, the interpretation of many of these studies on
comorbidity in absence seizure models is compromised by
several issues. First, the majority of these investigations did
not record the EEG during the behavioural tests, making it
impossible to ascertain how the observed changes in behav-
iour are linked to ictal and interictal periods. Second, in
studies using inbred absence seizure models, a comparison
with normal animals as well as inbred non-epileptic control
strains would be essential to control for potential effects of
long-term inbreeding of the non-epileptic strain (Marques-
Carneiro et al., 2014; Bombardi et al., 2018). Third, all but
two studies (Marks et al., 2016a; Henbid et al., 2017) have
used only male animals. Fourth, fear-reaction tests are not
the ideal procedure to study attention and memory in ab-
sence seizure models that have inherent anxiety- and depres-
sion-like comorbid conditions and should be replaced by
touch-screen technology (Markham et al., 1996).
Significance of new evidence
In summary, attention deficits are the most common psychi-
atric comorbidity of absence seizures when present as the
only seizure type: they may precede the first absence seizure
(i.e. are present in pre-symptomatic children), persist even
after seizures are pharmacologically controlled (Fig. 8) and
are much more frequent following monotherapy with val-
proic acid than ethosuximide or lamotrigine. Other cognitive
impairments and mood disorders may also be present
(Fig. 8), but systematic analyses of their incidence, life-pro-
gression and causal link with treatment are not yet available.
It is likely that the aberrant function of cortico-thalamo-cor-
tical networks (underlying the generation of SWD and ab-
sence seizures) (Crunelli and Leresche, 2002a; Blumenfeld,
2005a) combines with the abnormal activity of basal gan-
glia-limbic-monoamine networks (underlying attention defi-
cits, cognitive impairments and mood disorders) (De
Deurwaerde`re et al., 2017; Miskowiak and Petersen, 2019;
Park et al., 2019) to generate the overall neuropsychiatric
comorbid phenotype of absence seizure (Fig. 8, left).
Notably, anterior and mediodorsal thalamic nuclei, which
show consistent ictal BOLD changes in individuals with ab-
sence seizure (Tyvaert et al., 2009) and are crucial for atten-
tional control (Schmitt et al., 2017), provide a structural and
functional bridge between limbic and cortico-thalamo-cor-
tical networks (Jones, 2003). Moreover, alterations in cogni-
tion and memory may be significantly influenced by the
characteristic biophysical properties of thalamocortical neu-
rons (Connelly et al., 2015, 2016, 2017) and by the T-chan-
nel-mediated low-threshold spike and bursts that occur
during absence seizures, as long-term changes in the plasti-
city of thalamic synapses preferentially occur when thalamic
neurons fire T-channel bursts of action potentials and are
rarely observed when these neurons fire tonic single action
potentials (Sieber et al., 2013; Pigeat et al., 2015; Leresche
and Lambert, 2017; Crunelli et al., 2018). Unravelling the
true nature of the link between absence seizure epilepto-
genesis/ictogenesis and comorbidities, and understanding
whether and to what extent psychiatric comorbid condi-
tions are drug-induced and/or drug-aggravated (Fig. 8,
right) are hindered by the lack of data on the effects of
currently available anti-absence medicines on attention,
learning and mood in healthy humans and in normal
(young and adult) animals.
New treatments for absence
seizures and their psychiatric
comorbid conditions
The pharmaco-resistance of 30% of children with absence
seizure, the persistence of neuropsychiatric comorbidities in
seizure-free cohorts and the adverse effects of current medi-
cations (particularly in polytherapy) demand urgent action
on novel treatments. Naturally, the best therapy for any epi-
lepsy is one that would block epileptogenesis, i.e. has a dis-
ease-modifying effect. As far as current anti-absence drugs
are concerned, some limited evidence in children suggests
that early, effective treatment with ethosuximide has positive
long-term (510 years) outcomes, i.e. seizure- and medica-
tion-free (Berg et al., 2014). This potential disease-modifying
effect of ethosuximide is strongly supported by results in
WAG/Rij and GAERS rats showing that initiating treatment
with ethosuximide prior to seizure onset and continuing it
for 3–4 months not only fully blocks absence seizures even
3 months after the end of treatment and markedly reduces
comorbid anxiety (Blumenfeld et al., 2008; Dezsi et al.,
2013), but also increases the mRNA levels of DNA methyl-
transferases, a key component of epigenetic pathways, in the
CIN of GAERS rats (Dezsi et al., 2013) and abolishes the
abnormal expression of Nav1.1, Nav1.6 and HCN1 in
WAG/Rij rats (Blumenfeld et al., 2008). In contrast, a
shorter treatment (3–5 weeks) initiated even prior to seizure
onset does not protect GAERS rats after the end of the treat-
ment (Dedeurwaerdere et al., 2005; Jarre et al., 2017).
Indeed, when the start and the duration of the ethosuximide
treatment were directly compared in the same study on
WAG/Rij rats, only the 4-month treatment (but not the 2-
month treatment starting either at the second or fourth
month of life) was effective up to 2 months post-treatment
(van Luijtelaar et al., 2013). This suggests that either epi-
leptogenic mechanisms are still operant even when SWD ap-
pear to be fully developed or that an effective prophylactic
treatment needs to affect both epileptogenic and early epilep-
tic processes. Obviously, any potential future translation of
an early treatment to humans would require identification of
solid genetic (Noebels, 2015a; Holmes and Noebels, 2016)
or phenotypic biomarkers before the epileptogenic processes
have fully established themselves.
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As far as novel pharmacological therapies are concerned,
there is only one new medication (EpidiolexVR ), an oral form
of cannabidiol, a phytocannabinoid devoid of psychotropic
actions (Stockings et al., 2018), that is currently in phase 2
trials in children with pharmaco-resistant absence seizure
(ClinicalTrials.gov #NCT03336242; ClinicalTrials.gov
#NCT03355300). This is surprising and of concern as this
drug was shown to have no effect on non-convulsive
absence seizures in previous trials in two severe childhood
epilepsies, i.e. Lennox-Gastaux and Dravet syndromes
(Devinsky et al., 2019; Thiele et al., 2018). Moreover, to the
best of our knowledge there are no publicly available data
on the anti-absence effect of cannabidiol in mice and rats
with absence seizures and no study has investigated its po-
tential adverse effects on attention, cognition, learning and
memory both in normal non-epileptic young animals and in
absence seizure models.
As indicated previously, T-type Ca2+ channels of cortical
and NRT neurons are key to absence seizure expression
(McCafferty et al., 2018b) (Fig. 5). This suggests that potent
and selective T-channels blockers, in contrast to the weak and
non-selective actions of ethosuximide and valproic acid on
these channels (Leresche et al., 1998; Crunelli and Leresche,
2002a, b), may offer concrete hope for pharmaco-resistant
absence seizures. Regrettably, the first generation of potent
and selective T-channel blockers (Dreyfus et al., 2010) elicited
major changes in the vigilance states of absence seizure mod-
els (Shipe et al., 2008). However, a member of a new gener-
ation of state-dependent T-channel antagonists, CX-8998, is
currently in a phase 2 trial in adolescent and adult popula-
tions with generalized epilepsy and absence seizures that do
not respond to standard of care treatment (ClinicalTrials.gov
#NCT03406702, 2018). Moreover, Z944 (now called
PRAX-944), another pan-T-channel antagonist that blocks
experimental absence seizure and ameliorates some aspects of
their comorbidity, is in a phase 2 trial in an adult population
with pharmaco-resistant absence seizure (ANZCTR.). It is
hoped that CX-8998 and PRAX-944 may, in the near future,
be tested for their efficacy and safety in paediatric and juven-
ile cohorts with absence seizure.
As mentioned earlier, a loss-of-function of GAT-1 in some
rat and mouse genetic models leads to increased thalamic
GABA levels and to experimental absence seizures via activa-
tion of extrasynaptic d subunit-containing GABA-A recep-
tors (Cope et al., 2009). Thus, drugs that increase the
activity of GAT-1 and antagonists of d-containing GABA-A
receptors may represent new targets for treating absence
seizure (Errington et al., 2011a). Proof-of-concept for this
potential therapy is provided by the rescue of the absence
phenotype (and lack of adverse effects) in the off-springs of
stargazer mice crossed with GABA-A d-subunit knockout
mice (McCafferty et al., 2018a). Another interesting target
could be the 5-HT2C receptor (Di Giovanni and De
Deurwaerde`re, 2016), as selective agonists at these receptors
have been shown to dose-dependently block experimental
absence seizure (Venzi et al., 2016). Finally, positive allo-
steric modulators of metabotropic glutamate receptors 1 and
5, which are key to cortico-thalamic transmission (Baude
et al., 1993; Romano et al., 1995; Errington et al., 2011c),
block experimental absence seizures (D’Amore et al., 2015;
Celli et al., 2019), as does the selective thalamic block of
hyperpolarization-activated, cyclic nucleotide-gated channels
(David et al., 2018) (see also Hammelmann et al., 2019;
Zobeiri et al., 2019), opening up the possibility of selectively
targeting one of these receptor/channel subtypes for treating
CAE and other epilepsies with absence seizure.
Moving away from pharmaco-therapy, optogenetics has
been suggested as a potential future alternative to neurosur-
gery for adults with pharmaco-resistant epilepsies (Wykes
et al., 2012, 2016; Bui et al., 2017; Christenson Wick and
Krook-Magnuson, 2018). However, the inherent invasive-
ness of optogenetic techniques and the substantial incidence
of absence seizure remittance in CAE (Camfield and
Camfield, 2005) do not lead at present to a favourable risk-
benefit analysis for a standard optogenetic therapy. Notably
though, the brief reversible and safe opening of the blood–
brain barrier induced by non-invasive focused ultrasound in
a small brain region (Munoz et al., 2018) allows locally
restricted diffusion of an intravenously injected (virally-
driven) opsin in mice that can then be activated by transcra-
nial light stimulation (Pouliopoulos et al., 2018). In
principle, therefore, following the identification of the CIN
in an individual with absence seizures this technique does
provide the possibility of delivering and activating light-sen-
sitive proteins without surgical intervention. The safety and
reliability of focused ultrasound have already been tested in
healthy adults and people with other neurological diseases
(Carpentier et al., 2016; Lipsman et al., 2018) but has not
been investigated yet in younger populations.
Finally, the block of experimental absence seizures by
non-invasive transcranial electrical stimulation (Berenyi
et al., 2012; Liu et al., 2018) offers at present a more real-
istic potential than optogenetics and may have the add-
itional advantage of improving attention as shown in
some studies of adult populations (Reteig et al., 2017).
However, the implementation of both therapeutic
approaches will require improvements of existing algo-
rithms for absence seizure prediction (Maksimenko et al.,
2017). Moreover, as transcranial electrical stimulation has
been shown to affect brain oscillations and functional
connectivity (Krause et al., 2017, 2019) its application to
children and teenagers with absence seizures demands
knowledge of the long-term effects of repetitive electrical
stimulation on brain development before it might be con-
sidered a reliable and safe therapeutic avenue.
Future priorities
Mechanism of pre-ictal and abnormal interictal
activity
A key future challenge will be to uncover the electrical corre-
lates of the changes in BOLD signal amplitude and synchrony
that precede by tens of seconds and even up to 1 min, respect-
ively, the start of absence seizure in humans (Holmes et al.,
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2004; Bai et al., 2010, 2011; Tangwiriyasakul et al., 2018).
Detecting such early pre-ictal changes in EEG spike-wave
morphology, frequency, synchrony and/or coupling strength
will be fundamental for the development of efficient predic-
tion algorithms (Gadhoumi et al., 2016; Freestone et al.,
2017), which in turn are necessary for the potential imple-
mentation of transcranial electrical, optogenetic (or other
therapeutic/prophylactic) stimulation protocols. So far, no
study has systematically analysed the EEG at such early pre-
ictal periods in children with absence seizure, and the possibil-
ity cannot be discarded that the changes in electrical activity
underlying these early pre-ictal functional MRI alterations in
humans are preferentially confined to deep cortical layers
(Polack et al., 2007) and thus undetectable by standard EEG
electrodes.
From an experimental perspective, unambiguous changes
in cortical and thalamic single-neuron activity (Fig 4A)
(Pinault, 2003; McCafferty et al., 2018b; Meyer et al.,
2018), in the power of EEG theta, delta and beta frequency
bands and in inter-cortical area coupling strengths (Sysoeva
et al., 2014, 2016a, b; Sorokin et al., 2016) have been
reported in mouse and rat absence seizure models but they
all occur only around 2–4 s prior to seizure onset. As
changes in functional MRI BOLD signal are evident up to 1
min before absence seizure onset (Tangwiriyasakul et al.,
2018), does this large time difference in early pre-ictal
changes represent another key difference between human
and animal models because of their potentially different neu-
rovascular coupling? More generally, does it derive from our
lack of fully understanding the intricate relationship between
electrical and BOLD signals (Goense and Logothetis, 2008),
and/or is it a reflection of the fact that BOLD changes in
humans with epilepsy and in animal models may not neces-
sarily correlate with, or even relate to, abnormal neuronal
activity (Lemieux et al., 2011)?
The early pre-ictal changes of absence seizures are likely to
be tightly linked to the presence of a persistently, i.e. interic-
tally, altered cortical sensorimotor network in humans
with absence seizures compared to healthy controls
(Tangwiriyasakul et al., 2018). Future clinical studies should
confirm this finding in larger drug-free cohorts of CAE,
whereas the existence and location of similarly abnormal
networks during the interictal periods should be investigated
in absence seizure models with electrical and/or non-invasive
imaging approaches.
Mechanism of absence seizure initiation
Whereas the ictogenesis and the temporal dynamics of sin-
gle-cell interactions underlying cortico-thalamo-cortical
network activity in the cycle-by-cycle maintenance of
SWDs have started to be unravelled in non-anaesthetized
animal models (McCafferty et al., 2018b; Meyer et al.,
2018), we still lack knowledge of the cellular, synaptic
and network mechanisms that lead to absence seizure ini-
tiation in the CIN. Because of what has been discussed in
the previous point, it is of paramount importance that fu-
ture studies in animal models must strictly take into
account the fact that the dynamic state of single neurons
and neuronal networks of the CIN before the start of an
electrographic and behavioural absence seizure is not
identical to that of the same neurons and networks in a
control (i.e. non-epileptic) animal. Moreover, investiga-
tions of absence seizure initiation should carefully con-
sider the different location of the CIN among animal
models (Meeren et al., 2002; Studer et al., 2018; Lee
et al., 2019) and between models and children with ab-
sence seizures (Bai et al., 2010; Guo et al., 2016;
Tangwiriyasakul et al., 2018).
Understanding the absence seizure initiation process will
undoubtedly be a massive and technically highly demand-
ing task that will require an intelligent combination of
recording the firing dynamics of identified (or identifiable)
neurons from CIN neuronal ensembles in non-anaesthe-
tized animal models coupled with a systematic investigation
of subthreshold oscillations and passive and active mem-
brane properties of the various neuronal populations in
CIN slices. Some patchy experimental evidence does exist
but was obtained in cortical areas other than the CIN or
under anaesthetic conditions (D’Arcangelo et al., 2002;
Polack et al., 2007; Chipaux et al., 2011). Moreover, while
we know that layer 5/6 pyramidal neurons in the CIN of
absence models have different intrinsic membrane proper-
ties (Kole et al., 2007; Polack et al., 2007) and morpho-
logical features (van Luijtelaar and Sitnikova, 2016) than
non-epileptic animals, similar information is not available
for the different classes of CIN interneurons. Furthermore,
there are no data on potential abnormalities of synaptic
innervation, strength and plasticity among excitatory and
inhibitory neurons in the CIN of any absence seizure
model. Indeed, some of the key differences that exist in
normal animals between parvalbumin- and somatostatin-
positive cortical interneurons (Ascoli et al., 2008) may be
altered in the CIN of absence seizure models. Notably, se-
lective inhibition by DREADDS of cortical parvalbumin-
positive interneurons has been shown to elicit absence-like
seizures in normal mice (Panthi and Leitch, 2019) and gen-
etic ablation of Cav2.1 channels in both parvalbumin- and
somatostatin-positive cortical interneurons elicit severe
generalized seizures and absence seizures (Rossignol et al.,
2013). However, whether and how somatostatin-positive
interneurons, the main mediators of the dendritic inhib-
ition-dependent regulation of input-output transformations
in pyramidal neurons (Lovett-Barron et al., 2012; Wilson
et al., 2012; Lee et al., 2013), may contribute to absence
seizure generation remains to be established. Moreover,
somatostatin-positive interneurons in the somatosensory
cortex are active during quiet wakefulness, the brain state
where most absence seizures are expressed (Hala´sz, 2015)
and their silencing increases burst firing in cortical pyram-
idal neurons (Gentet et al., 2012).
Mechanism of absence seizure termination
The mechanism underlying the termination of absence seiz-
ures has not been directly investigated. Changes in Granger
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causality values among the activity of cortical and subcor-
tical regions (Lu¨ttjohann et al., 2014) as well as changes in
the firing of cortical, thalamic and basal ganglia neuronal
populations just around SWD offset have been proposed as
potential contributors to absence seizure termination (Paz
et al., 2005, 2007; McCafferty et al., 2018b) but no causal
evidence is available.
From a biophysical perspective, as elegantly summarized
by Bartho´ et al. (2014), the length of a SWD (as any other
spontaneous transient oscillation) could either be predeter-
mined by the state of the generating network at the start of
the SWD or depend on the arrival of a signal (intrinsic or
extrinsic to the generating network) at any time after the
SWD has started. In the former case, the activity of each
SWD follows a fixed trajectory and thus the time of its ter-
mination is set by the initial state of the network, whereas
in the latter case there is no correlation between the initial
and the end state of the SWD-generating network and thus
the length (and time of termination) of a SWD.
Understanding which of these two scenarios applies to
SWD is of paramount importance as it will help to guide
more detailed research towards either the key elements that
set the conditions of the SWD-generating network at the
start of a SWD or the intrinsic and extrinsic perturbations
that bring to a stop the activity of the SWD-generating net-
work. Notably, the correlation between EEG-functional
MRI data and cognitive impairments during absence seizure
in children with CAE has been shown to be already set at
the very start of a seizure (Guo et al., 2016).
Because of the hypothesis linking natural sleep spindles (a
spontaneous transient oscillation) and SWD of absence seiz-
ure (Avoli and Gloor, 1981; Kostopoulos et al., 1981; but
see Leresche et al., 2012), currently proposed mechanisms of
sleep spindle termination might apply to SWD, though spin-
dles are driven by a thalamic pacemaker with critical cortical
modulation (Steriade et al., 1987; Crunelli et al., 2018;
Adamantidis et al., 2019; Fernandez and Luthi, 2020) where-
as absence seizures require the contribution of many different
neuronal populations in cortico-thalamo-cortical and basal
ganglia networks. Thus, increased intracellular Ca2+ leading
to thalamocortical neuron depolarization (Lu¨thi and
McCormick, 1998; Lu¨thi et al., 1998), desynchronization of
the cortical output to the thalamus (Bonjean et al., 2011)
and progressive hyperpolarization of NRT neurons (Bal
et al., 1995b; Kim and McCormick, 1998) coupled with a
marked drop in their firing just a few cycles before spindle
termination (Bartho´ et al., 2014), that have been suggested
as potential mechanisms for spindle termination, might also
be involved in controlling the duration of SWD. Notably, the
latter mechanism has been shown to be predetermined by the
state of the network at the start of the spindle oscillation in
normal (i.e. non-epileptic) rats (Bartho´ et al., 2014).
Finally, the slowing of the rhythmic activity in both excita-
tory and inhibitory neurons towards the end of partial
(focal) seizures has been suggested to involve a progressive
increase in synchrony among participating neurons and to
play a role in seizure termination (de Curtis and Avoli,
2015). As a slowing of the SWD frequency is observed with-
in many absence seizure (Fig. 1A) (Panayiotopoulos, 1999;
Blumenfeld, 2005b; Matricardi et al., 2014) it could be that
an increased synchronization of cortical excitatory and in-
hibitory networks in the CIN may also be critical for ab-
sence seizure termination.
Mechanism of absence seizure pharmaco-resistance
If we want to prevent the adverse effects of polytherapy, we
need to understand the mechanisms underlying pharmaco-
resistant absence seizures. As these seizures are genetically
determined, a key goal would be to increase efforts in inves-
tigating differences in genetic abnormalities between
responders and non-responders to currently available
anti-absence medications in large cohorts. For experimental
research, the priority would be to develop animal models
that are insensitive to ethosuximide and valproate. Such a
development may be guided by the findings in humans that
(i) a more negative treatment outcome, independently of the
initial treatment (with either ethosuximide, valproic acid or
lamotrigine), occurs for absence seizure without face/limb
motor automatisms (Kessler et al., 2017); (ii) ethosuximide
responders have decreased parietal cortex connectivity for
ictal low frequency EEG components whereas non-respond-
ers have increased frontal cortex connectivity for high fre-
quencies (Tenney et al., 2018); and (iii) a CACNA1H
polymorphism (P640L) is more commonly expressed in chil-
dren non-responding to ethosuximide monotherapy (Glauser
et al., 2017).
Mechanism and treatment of absence seizure
comorbidities
A major future research task relates to the inability of cur-
rent therapies to effectively control absence seizure comor-
bidities since we have no indication as to whether absence
seizures and comorbidities share initial common genetic and
mechanistic pathways that once fully developed become in-
dependent from each other (Sharp et al., 2008; Fejgin et al.,
2014; Noebels, 2015b; Nilsson et al., 2016). Clinically, the
persistence of interictally altered cortical networks
(Tangwiriyasakul et al., 2018) calls for routine pre-symp-
tomatic functional MRI and neuropsychiatric analysis for
early detection of abnormal cortical network functions in
children and teenagers at risk of developing absence seizures.
Experimentally, the neuropsychiatric features of absence
seizure models should be systematically investigated to
understand the underlying neurobiological mechanisms and
assess potential treatments. At present, the only drug that
has been shown to abolish absence seizures and ameliorate
memory deficits in animal models is the pan-T-channel
blocker Z944 (Marks et al., 2016a; Henbid et al., 2017): se-
lective antagonists for one T-channel subtype may prove
more effective than pan T-channel blockers in controlling
both absence seizure and associated comorbidity (Powell
et al., 2014a).
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Valproic acid-induced comorbidity and continuous
neuropsychiatric evaluation
The large incidence of neuropsychiatric comorbidities and
the marked increase in attention deficits observed with val-
proic acid treatment in CAE (Masur et al., 2013) advise
against the use of this drug as first monotherapy in children
and teenagers with absence seizures. Moreover, the presence
of widespread psychiatric comorbidity in individuals with
absence seizures makes it of paramount importance to estab-
lish closer interactions between neurologists and psychiatrists
as part of the standard clinical practice in the initial assess-
ment and continuous follow-up of children and teenagers
with CAE, juvenile absence epilepsy and juvenile myoclonic
epilepsy. The major efforts that are currently being made to-
wards a better understanding and treatment of attention,
cognition and learning deficits and mood disorders (Duman
et al., 2016; Postorino et al., 2017; Feldman et al., 2018)
will undoubtedly also prove beneficial to children, teenagers
and adults with absence seizures.
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